About this trial
In recent years, especially in developed countries, FMS has emerged as a serious social problem by decreasing labour force and quality of life. Especially clinicians have started to consider cognitive dysfunction in FMS as a separate clinical condition. In the light of the data obtained, can say that cognitive dysfunction increases in the presence of depression, anxiety, sleep disorders, endocrine imbalances and pain.
Neuroscience and technological advances make it possible to meet the demand for care and improve the quality of stimulation by enabling the automation of many cognitive training procedures, improving patient record reliability and optimising performance of disability functions. The recently implemented RehaCom and HeadApp programmes (Schuhfried, Austria). excellent results have been reported in clinical practice with no significant adverse effects.
This study will investigate the effectiveness of a cognitive rehabilitation programme using computer software in female patients with fibromyalgia.
Eligibility criteria
Qualifiers
Being a woman
Diagnosed with fibromyalgia
18-65 years old
Disqualifiers
concomitant neurological disorder, learning disorder or cognitive impairment
current alcohol or recreational drug dependence or long-term (≥5 years) history of substance abuse
visual or hearing impairment that would interfere with cognitive testing
diagnosis of untreated obstructive sleep apnoea,
Trial design
Treatments tested in this trial
- cognitive rehabilitation with computer software
Treatment groups
Locations
Sponsors and collaborators
Savaş Karpuz
Lead sponsor
Konya Beyhekim Training and Research Hospital
Sponsor institution